Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss

Tain, Luke S, Mortiboys, Heather, Tao, Ran N, Ziviani, Elena, Bandmann, Oliver, Whitworth, Alexander J·2009·Nature Neuroscience

DOI 10.1038/nn.2372

Cited by (323)

Items 201–300 of 323

FOXO3a‐dependent Parkin regulates the development of gastric cancer by targeting ATP‐binding cassette transporter E1
Dan Ding, Xiang Ao, Mengyang Li, Shuo Miao, Ying Liu, Zhijuan Lin, Mengyu Wang, Yuqi He, Jianxun Wang · 2020 · Journal of Cellular Physiology
Dietary Amino Acids Impact LRRK2-Induced Neurodegeneration in Parkinson's Disease Models
Vinita G. Chittoor-Vinod, Steffany Villalobos-Cantor, Hanna Roshak, Kelsey Shea, Leire Abalde-Atristain, Ian Martin · 2020 · Journal of Neuroscience
Ketamine Exhibits Different Neuroanatomical Profile After Mammalian Target of Rapamycin Inhibition in the Prefrontal Cortex: the Role of Inflammation and Oxidative Stress
Helena M. Abelaira, Gislaine Z. Réus, Zuleide Maria Ignácio, Maria Augusta B. dos Santos, Airam Barbosa de Moura, Danyela Matos, Júlia P. Demo, Júlia B.I. da Silva, Lucinéia Gainski Danielski, Fabricia Cardoso Petronilho et al. · 2016 · Molecular Neurobiology
Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?
Mohammad Jodeiri Farshbaf, Kamran Ghaedi · 2016 · BioMetals
Effects and potential mechanisms of rapamycin on MPTP-induced acute Parkinson’s disease in mice
Guifang Zhang, Lishi Yin, Zhenchun Luo, Xuemei Chen, Yanping He, Xie Yu, Ming Wang, Fengwei Tian, Haiyan Luo · 2021 · Annals of Palliative Medicine
Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics Analysis
Wei Quan, Jia Li, Xiya Jin, Li Liu, Qinghui Zhang, Yidan Qin, Xiaochen Pei, Jiajun Chen · 2021 · Parkinson s Disease
Precision Medicine in Parkinson’s Disease: From Genetic Risk Signals to Personalized Therapy
Giulia Straccia, Fabiana Colucci, Roberto Eleopra, Roberto Cilia · 2022 · Brain Sciences
Alleviation of cisplatin-induced neuropathic pain, neuronal apoptosis, and systemic inflammation in mice by rapamycin
Moureq Rashed Alotaibi, Faten Abdullah Alaqil, Faleh Alqahtani, Miteb Alanazi, Ahmed Nadeem, Sheikh F. Ahmad, Rebeca Lapresa, Metab Alharbi, Abdulrahman Alshammari, Muteb Alotaibi et al. · 2022 · Frontiers in Aging Neuroscience
Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells
Santiago Ramón y Cajal · 2011 · Oncology Reports
Two mTOR inhibitors, rapamycin and Torin 1, differentially regulate iron-induced generation of mitochondrial ROS
Hui Huang, Jun Chen, Huiru Lu, Mengxue Zhou, Zhifang Chai, Yi Hu · 2017 · BioMetals
Pharmacological mTOR-inhibition facilitates clearance of AD-related tau aggregates in the mouse brain
Martina P. Morawe, Fan Liao, Willi Amberg, Jeroen van Bergeijk, Rui Chang, Mary Gulino, Caitlin Hamilton, Carolin Hoft, Casey J. Lumpkin, Bryan Mastis et al. · 2022 · European Journal of Pharmacology
Targeting Mitochondria for Neuroprotection in Parkinson Disease
Anthony H.V. Schapira, Sandip Patel · 2014 · JAMA Neurology
A Neuron-Glial Trans-Signaling Cascade Mediates LRRK2-Induced Neurodegeneration
Élie Maksoud, Edward H. Liao, Ali Pejmun Haghighi · 2019 · Cell Reports
Progress on stem cell research towards the treatment of Parkinson's disease
Stuart AJ Gibson, Guodong Gao, Katya McDonagh, Sanbing Shen · 2012 · Stem Cell Research & Therapy
Modeling LRRK2 Pathobiology in Parkinson’s Disease: From Yeast to Rodents
Guillaume Daniel, Darren J. Moore · 2014 · Current topics in behavioral neurosciences
SIL1, the ER Hsp70 co-chaperone, plays a critical role in maintaining skeletal muscle proteostasis and physiology
Viraj P. Ichhaporia, Jieun Kim, Kanisha Kavdia, Peter Vogel, LINDA H. HORNER, Sharon Frase, Linda M. Hendershot · 2018 · Disease Models & Mechanisms
Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in Drosophila
Andrew Rallis, Bingwei Lu, Julian Ng · 2012 · Journal of Cell Science
Crossregulation of rapamycin and elaiophylin biosynthesis by RapH in Streptomyces rapamycinicus
Wenyan He, Wenfang Wang, Jiaxiang Ma, Guosong Zheng, Andrei Antonovich Zimin, Weihong Jiang, Jinzhong Tian, Yinhua Lü · 2022 · Applied Microbiology and Biotechnology
Histone Deacetylase 4 Inhibition Reduces Rotenone-Induced Alpha-Synuclein Accumulation via Autophagy in SH-SY5Y Cells
Luxi Wang, Ling Liu, Chao Han, Haiyang Jiang, Kai Ma, Shiyi Guo, Yun Fei Xia, Fang Jung Wan, Jinsha Huang, Nian Xiong et al. · 2023 · Brain Sciences
Invertebrate models of lysosomal storage disease: what have we learned so far?
Samantha J. Hindle, Sarita Hebbar, Sean T. Sweeney · 2011 · Invertebrate Neuroscience
Deciphering the pathways that protect from IL-13-mediated potentiation of oxidative stress-induced dopaminergic nerve cell death
Pamela A Maher, Bruno Conti · 2017 · Cytokine
Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease
Gabrielle Zuniga, Sakie Katsumura, Jasmine De Mange, Paulino Ramirez, Farzaneh Atrian, Masahiro Morita, Bess E Frost · 2024 · Aging Cell
Mitochondrial Regulation by PINK1-Parkin Signaling
Yuzuru Imai · 2012 · ISRN Cell Biology
MiR‐133b‐5p regulates the expression of the heat shock protein 70 during rat neuronal cell apoptosis induced by the gp120 V3 loop peptide
Chenglai Xia, Yantao Cai, Yu-Yi Lin, Ronghua Guan, Guohong Xiao, Jie Yang · 2015 · Journal of Medical Virology
Caffeine Potentiates Ethanol-Induced Neurotoxicity Through mTOR/p70S6K/4E-BP1 Inhibition in SH-SY5Y Cells
Pongsak Sangaunchom, Permphan Dharmasaroja · 2020 · International Journal of Toxicology
Stereoselective Synthesis of Rapamycin Fragment To Build a Macrocyclic Toolbox
Shiva Krishna Reddy Guduru, Ravikumar Jimmidi, Girdhar Singh Deora, P. Arya · 2015 · Organic Letters
It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin)
Ester Aso, Isidró Ferrer · 2013 · Expert Opinion on Biological Therapy
The TORC1 inhibitor Nprl2 protects age-related digestive function in Drosophila
Junmeng Xi, Jiadong Cai, Cheng Yang, Yuanyuan Fu, Wanhong Wei, Zhenbo Zhang, Ziheng Zhuang, Yue Hao, Mary A. Lilly, Youheng Wei · 2019 · Aging
Movement disorders: advances in cause and treatment
Anthony H.V. Schapira · 2009 · The Lancet Neurology
Fine-Tuning of PI3K/AKT Signalling by the Tumour Suppressor PTEN Is Required for Maintenance of Flight Muscle Function and Mitochondrial Integrity in Ageing Adult Drosophila melanogaster
Lawrence B. Mensah, Claire Davison, Shih‐Jung Fan, John F. Morris, Deborah C. I. Goberdhan, CLIVE G. WILSON · 2015 · PLoS ONE
Targeting mRNA translation in Parkinson’s disease
Danilo Correddu, Ivanhoe K. H. Leung · 2019 · Drug Discovery Today
Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson’s Disease
Yuan Tan, Minjing Ke, Zhijian Huang, Cheong‐Meng Chong, Xiaotong Cen, Jiahong Lu, Xiaoli Yao, Dajiang Qin, Huanxing Su · 2019 · Aging and Disease
Diminution of eIF4E activity suppresses parkin mutant phenotypes
Cristina Ottone, Alessia Galasso, Marica Gemei, Viviana Pisa, Silvia Gigliotti, Federica Piccioni, Franco Graziani, Arturo C. Verrotti · 2010 · Gene
Etiology and Pathogenesis of Parkinson Disease
Ruth‐Mary deSouza, Anthony H.V. Schapira · 2017 · Neurodegeneration
Drosophila Models of Parkinson's Disease☆
Alexander J. Whitworth · 2016 · Elsevier eBooks
LRRK2 Parkinson’s disease: from animal models to cellular mechanisms
Chin‐Hsien Lin, Pei-I Tsai, Ruey‐Meei Wu, Cheng‐Ting Chien · 2011 · Reviews in the Neurosciences
Phosphorylated S6K1 and 4E-BP1 play different roles in constitutively active Rheb-mediated retinal ganglion cell survival and axon regeneration after optic nerve injury
Jikuan Jiang, Lusi Zhang, Jingling Zou, Jingyuan Liu, Jia Yang, Qian Jiang, Peiyun Duan, Bing Jiang · 2023 · Neural Regeneration Research
Does drug repurposing bridge the gaps in management of Parkinson’s disease? Unravelling the facts and fallacies
Bushra Bashir, Sukriti Vishwas, Gaurav Gupta, Keshav Raj Paudel, Harish Dureja, Puneet Kumar, Hyunah Cho, Vrashabh V. Sugandhi, Popat Kumbhar, John Disouza et al. · 2025 · Ageing Research Reviews
mTORC1-Dependent Protein and Parkinson’s Disease: A Mendelian Randomization Study
Cheng Tan, J. Ai, Ye Zhu · 2023 · Brain Science
Natural Products That Contain Higher Homologated Amino Acids
Skyler L. Owens, Shopno R. Ahmed, Rebecca M. Lang Harman, Laura E. Stewart, Shogo Mori · 2024 · ChemBioChem
mTOR and Neuroinflammation
Filipe Palavra, A. Ambrósio, F. Reis · 2016 · Elsevier eBooks
Genetically encoded biosensors of metabolic function for the study of neurodegeneration, a review and perspective
Minglei Zhao, Saman Behboodi Tanourlouee, Sean McCracken, Philip Raymond Williams · 2025 · Neurophotonics
Molecular targets and approaches to restore autophagy and lysosomal capacity in neurodegenerative disorders
Julie Bastien, Suchithra Menon, Mirko Messa, Beat Nyfeler · 2021 · Molecular Aspects of Medicine
Drosophila as a model to study autophagy in neurodegenerative diseases and digestive tract
Fei‐Yang Tzou, Jung‐Kun Wen, Jui‐Yu Yeh, Shu‐Yi Huang, Guang‐Chao Chen, Chih‐Chiang Chan · 2021 · IUBMB Life
Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease
Alika Sarkar, Mohd Sami Ur Rasheed, Mahendra Pratap Singh · 2022 · Antioxidants and Redox Signaling
The 4E-BPs as Translational Regulators in Neurological Disorders: Molecular Mechanisms and Therapeutic Potential
Sindhu S Baskarapantula, Venkata Surya Kumar, Priyajit Changdar, Debashree Chakraborty, Yogendra Nayak, Albert R. La Spada, Craig L. Bennett, Somasish Ghosh Dastidar · 2025 · Molecular Neurobiology
Mechanisms and early efficacy data of caloric restriction and caloric restriction mimetics in neurodegenerative disease
Anchal Trisal, Abhishek Kumar Singh · 2025 · Neuroscience
The mTOR Signaling Pathway in Neurodegenerative Diseases
Arnaud Francois, Julie Vérité, Agnès Rioux Bilan, Thierry Janet, Frédéric Calon, Bernard Fauconneau, Marc Paccalin, Guylène Page · 2016 · Elsevier eBooks
Reduced Glucose Sensation Can Increase the Fitness of Saccharomyces cerevisiae Lacking Mitochondrial DNA
Emel Akdoğan, Mehmet Tardu, Görkem Garipler, Gülkız Baytek, İbrahim Halil Kavaklı, Cory D. Dunn · 2016 · PLoS ONE
Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson’s Disease
Tao Jin, Xuling Tan, Xiaoliu Shi, Lingling Lv, Xinke Peng, Hainan Zhang, Beisha Tang, Chunyu Wang, Mei Yang · 2020 · NeuroMolecular Medicine
Rapamycin Pretreatment Attenuates High Glucose-induced Alteration of Synaptic Transmission in Hippocampal Dentate Gyrus Neurons
Tianyue Jiang, Wenxin Zhang, Yue Wang, Tao Zhang, Haiyun Wang, Zhuo Ru Yang · 2022 · Neuroscience
Transcriptional landscapes at the intersection of neuronal apoptosis and substance P-induced survival: exploring pathways and drug targets
Simona Paparone, Cinzia Severini, Maria Teresa Ciotti, Velia D’Agata, Pietro Calissano, Sebastiano Cavallaro · 2016 · Cell Death Discovery
Parkinson’s Disease: Insights from Drosophila Model
Mohamad Ayajuddin, Abhik Das, Limamanen Phom, Priyanka Modi, Rahul Chaurasia, Zevelou Koza, Abuno Thepa, Nukshimenla Jamir, Pukhrambam Rajesh Singh, Sentinungla Longkumer et al. · 2018 · InTech eBooks
Insights into the metabolic mechanism of rapamycin overproduction in the shikimate-resistant Streptomyces hygroscopicus strain UV-II using comparative metabolomics
Huiyan Geng, Huanhuan Liu, Jiao Liu, Cheng Wang, Jianping Wen · 2017 · World Journal of Microbiology and Biotechnology
Identification of PP2A and S6 Kinase as Modifiers of Leucine-Rich Repeat Kinase-Induced Neurotoxicity
Joan Poh Ling Sim, Ziyin Wang, Adeline Henry Basil, Shuping Lin, Zhongcan Chen, Chengwu Zhang, Li Zeng, Yu Cai, Kah‐Leong Lim · 2019 · NeuroMolecular Medicine
Pathways of protein synthesis and degradation in PD pathogenesis
Rebekah G. Langston, Mark Cookson · 2020 · Progress in brain research
Alpha-ketoglutaric acid mitigates the detrimental effects of soy antigenic protein on the intestinal health and growth performance of Mirror carp Cyprinus carpio
Zuliang Zhou, Jianhua Zhao, Clement Roy de Cruz, Hong Tao Xu, Liansheng Wang, Qiyou Xu · 2023 · Fish Physiology and Biochemistry
Inflammation: Role in Parkinson's Disease and Target for Therapy
Patrick M. Flood, Naik Arbabzada, Monika Sharma · 2016 · InTech eBooks
Non-mammalian animal models of Parkinson's disease for drug discovery
Kah‐Leong Lim · 2010 · Expert Opinion on Drug Discovery
Rapamycin Plays a Pivotal Role in the Potent Antifungal Activity Exhibited Against Verticillium dahliae by Streptomyces iranensis OE54 and Streptomyces lacaronensis sp. nov. Isolated from Olive Roots
Carla Calvo-Peña, Marina Ruíz-Muñoz, Imen Nouioui, Sarah Kirstein, Meina Neumann‐Schaal, José María Sánchez-López, Seyedehtannaz Ghoreshizadeh, Rebeca Cobos, Juan José R. Coque · 2025 · Microorganisms
Protein Translation in Parkinson’s Disease
Jungwoo Wren Kim, Leire Abalde-Atristain, Huijue Jia, Ian Martin, Ted M. Dawson, Valina Lynn Dawson · 2017 · Elsevier eBooks
Insulin and TLR4 Inhibitor Improve Motor Impairments in a Rat Model of Parkinson’s Disease
Fatemeh Hemmati, Neda Valian, Abolhassan Ahmadiani, Zahurin Mohamed, Azman Ali Raymond, Norlinah Mohamed Ibrahim, Seyed Farshad Hosseini Shirazi · 2024 · Iranian journal of pharmaceutical research
Identification of Key Active Constituents in Eucommia ulmoides Oliv. Leaves Against Parkinson’s Disease and the Alleviative Effects via 4E-BP1 Up-Regulation
Yuqing Li, Ruidie Shi, Lijie Xia, Xuanming Zhang, Pengyu Zhang, Siyuan Liu, Kechun Liu, Attila Gabor SIK, Rostyslav S. Stoika, Meng Jin · 2025 · International Journal of Molecular Sciences
Narrative Review “Dual Frontiers in Neurodegeneration: Pharmacological Synergies and Divergences in Parkinson’s Disease and Type 2 Diabetes Mellitus”
Omnya A. Sharallah, Vishnu Kumar Malakar, Ahmed E. Salama, Salma M. Elmaaz, Salma A. Daba, Nitesh Kumar Poddar · 2026 · Cellular and Molecular Neurobiology
Pharmacology of Aging: Drosophila as a Tool to Validate Drug Targets for Healthy Lifespan
Helena M. Cochemé, Eliano dos Santos · 2024
LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease
Cristina Ciampelli, Grazia Galleri, Manuela Galioto, Paolo Mereu, Monica Pirastru, Roberto Bernardoni, Diego Albani, Claudia Crosio, Ciro Iaccarino · 2025 · International Journal of Molecular Sciences
Mammalian Target of Rapamycin (mTOR), Aging, Neuroscience, and Their Association with Aging-Related Diseases
Ergul Dilan Celebi-Birand, Elif Tugce Karoglu-Eravsar, Fusun Doldur-Balli, Michelle M. Adams · 2016 · Elsevier eBooks
Translational Control Through the EIF4E Binding Proteins in the Brain
Argel Aguilar‐Valles, Edna Matta‐Camacho, Nahum Sonenberg · 2018 · Oxford University Press eBooks
Revealing and evaluation of antivirals targeting multiple druggable sites of RdRp complex in SARS-CoV-2
Ruchi Rani, Sanketkumar Nehul, Shweta Choudhary, Anushka Upadhyay, Gaurav Kumar Sharma, Pravindra Kumar, Shailly Tomar · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Rapamycin and Autophagy: Potential Therapeutic Approach for Parkinson's Disease Treatment
Ahsas Goyal, Anuradha Kumari, Aanchal Verma, Neetu Agrawal · 2025 · CNS & Neurological Disorders - Drug Targets
Modeling of Human Parkinson’s Disease in Fly
Souradip Chatterjee, Pradeep Kumar Bhaskar, Ashim Mukherjee, Mousumi Mutsuddi · 2019 · Springer eBooks
Facile synthesis of rapamycin-peptide conjugates as mTOR and Akt inhibitors
Shalini Singh, Rafat Ali, Javed Miyan, Varsha Singh, Sanjeev Meena, Mohammad Hasanain, Smrati Bhadauria, Dipak B. Datta, Jayanta Sarkar, Wahajul Haq · 2021 · Organic & Biomolecular Chemistry
Translational Control of Synaptic Plasticity and Memory
Arkady Khoutorsky, Christos G. Gkogkas, Nahum Sonenberg · 2012 · Springer eBooks
Translate This … during Dietary Restriction
Brian Keith Kennedy, Vivian L. MacKay · 2009 · Cell Metabolism
Unraveling LRRK2 Pathogenesis: Common Pathways for Complex Genes?: Figure 1.
Emma Deas, Laura Dunn · 2010 · Journal of Neuroscience
Kinase Signaling Dysfunction in Parkinson's Disease: A Reverse Genetic Approach in Drosophila
Yong Huang, Sushila A. Shenoy, Bingwei Lu, Wencheng Liu, Chenjian Li · 2012 · Journal of Neurogenetics
Is Modulating Translation a Therapeutic Option for Huntington’s disease?
Flaviano Giorgini · 2011 · Neurodegenerative Disease Management
Rapamycin did not prevent the excessive exercise-induced hepatic fat accumulation
Ana P. Pinto, Alisson Luiz da Rocha, Giovana Rampazzo Teixeira, Rafael L. Rovina, Allice Santos Cruz Veras, Fabiani Gai Frantz, José Rodrigo Pauli, Leandro Pereira de Moura, Dennys E. Cintra, Eduardo Rochete Ropelle et al. · 2022 · Life Sciences
Insulin and toll-like receptor 4 interaction in the rat model of Parkinson’s disease induced by lipopolysaccharide
Fatemeh Hemmati, Neda Valian, Abolhassan Ahmadiani, Zahurin Mohamed, Azman Ali Raymond, Norlinah Mohamed Ibrahim, Seyed Farshad Hosseini Shirazi · 2024 · Physiology and Pharmacology
Absence of pretaporter restrains features of the parkin phenotype in Drosophila
María Constanza Silvera, Rafael Cantera, Maria Jose Ferreiro · 2024 · Experimental Neurology
Parkin and Parkinson’s Disease
Shiam-Peng Tay, Grace G.Y., Calvin W.S., Kah‐Leong Lim · 2011 · InTech eBooks
Novel therapies in the treatment of Parkinsons disease
Manali Mahajan, Swapnil Narayan Deshmukh, Sujata Dudhgaonkar · 2016 · International Journal of Pharmacological Research
Regulation of Synaptic Homeostasis by Translational Mechanisms
Megumi Mori, Jay Penney, Ali Pejmun Haghighi · 2019 · Oxford University Press eBooks
Effects of Glycerol and Shikimic Acid on Rapamycin Production in Streptomyces rapamycinicus
Huyen Thi Huong La, Thao Kim Nu Nguyen, Hang Thuy Dinh, Quyen Minh Huynh Nguyen, Minh Hong Nguyen · 2020 · Microbiology and Biotechnology Letters
LRRK2 genetics and expression in the Parkinsonian brain
Simone Sharma · 2010 · UCL Discovery (University College London)
Progress Toward Therapies and Interventions for Neurodevelopmental Disorders
Ayokunmi Ajetunmobi, Daniela Tropea · 2015 · Wiley eBooks
Avaliação da ação antiparkinsoniana do peptídeo Neurovespina no modelo murino da Doença de Parkinson
Gabriel Avohay Alves Campos · 2016
Characterization of Vesicular Monoamine Transporter 2 and its role in Parkinson's Disease Pathogenesis using Drosophila
Antonio Joel Tito, Sheng Zhang · 2016 · Digital Commons-TMC (Texas Medical Center)
Proteostatic Signaling & Control of Protein Synthesis
AJ Keefe · 2018 · Preprints.org
Unc 51–like autophagy-activating kinase (ULK1) mediates clearance of free α-globin in β-thalassemia
Christophe Lechauve, Julia Keith, Eugene Khandros, Stephanie Fowler, Kalin Mayberry, Abdullah Freiwan, Christopher S. Thom, Paola Delbini, Emilio Boada Romero, Jingjing Zhang et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
The Role of BiP Co-chaperone SIL1 in Marinesco-Sjögren Syndrome Pathogenesis
Viraj P. Ichhaporia · 2018
Proteostatic Signaling & Control of Protein Synthesis
AJ Keefe · 2018 · Preprints.org
Uruguayan Insect Research: Seven Decades Shaping Neuroscience
María Constanza Silvera, Daniel Prieto · 2024
Enhanced mTORC1 signaling and Protein Synthesis in Parkinson’s Disease Pathogenesis Disease Pathogenesis
Khan, Mohammed Repon, Yin, Xiling, Kang, Sung-Ung, Mitra, Jaba, Wang, Hu, Brahmachari, Saurav, Karuppagounder, Senthilkumar S., Kimura, Yasuyoshi, Jhaldiyal, Aanishaa, Kim, Hyun Hee et al. · 2022
The Protective Role of Sestrins Against Chronic TOR Activation and Oxidative Stress
Jun Hee Lee, Ethan Bier · 2011 · Wiley eBooks
Modeling LRRK2 Parkinsonism
Kelly M. Hinkle, Heather L. Melrose · 2011 · InTech eBooks
Protein Degradation in Neurodegeneration: The Ubiquitin Pathway
Lynn Bedford, Robert Layfield, Nooshin Rezvani, Simon Paine, James S Lowe, R. John Mayer · 2011 · Wiley eBooks
Mitochondria fingerprint longevity in iPSCs
Andrea Masotti, Enrico Bertini, Claudia Compagnucci · 2015 · Oncotarget
A D. melanogaster parkin mutant larval model of Parkinson's Disease
Amanda Vincent · 2013 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Can pharmacological activation of 4E-BP suppress PD?
Eleanor Beal · 2009 · Nature Reviews Neurology